Here is the related vocabulary words/terms grouped in Pharmaceutics.
A stain that differentiates cells that have waxy mycolic acids in their gram-positive cell walls
a chromophore with a negative charge that attaches to positively charged structures
A skin disease in which hair follicles or pores become clogged, leading to the formation of comedones and infected lesions
Disease caused by HIV, characterized by opportunistic infections and rare cancers
A protein that polymerizes to form microfilaments
Energy needed to form or break chemical bonds and convert a reactant or reactants to a product or products
Protein that increases the transcription of a gene in response to an external stimulus.
An infected individual who can transmit the pathogen to others regardless of whether symptoms are currently present
Stimulation of one’s own adaptive immune responses.
Inflammation of the glomeruli of the kidney, probably resulting from deposition of immune complexes and an autoimmune response caused by self-antigen mimicry by a pathogen.
A severe form of gingivitis, also called trench mouth.
Inflammatory disease of the middle ear resulting from a microbial infection.
autoimmune disease affecting adrenal gland function
purine nitrogenous base found in nucleotides
nucleotide derivative and relative of ATP containing only one high-energy phosphate bond
adenine molecule bonded to a ribose molecule and to a single phosphate group, having no high-energy phosphate bonds
energy currency of the cell; a nucleotide derivative that safely stores chemical energy in its two high-energy phosphate bonds
the capability of microbes to attach to host cells
use of an oxygen molecule as the final electron acceptor of the electron transport system
a method for separating populations of DNA molecules of varying sizes by differential migration rates caused by a voltage gradient through a horizontal gel matrix
binding of different pathogen cells by Fab regions of the same antibody to aggregate and enhance elimination from body
leukocytes that lack granules in the cytoplasm
any of various unicellular and multicellular photosynthetic eukaryotic organisms; distinguished from plants by their lack of vascular tissues and organs
antigen capable of inducing type I hypersensitivity reaction
hypersensitivity response to an allergen
molecule that binds to an enzyme’s allosteric site, increasing the affinity of the enzyme’s active site for the substrate(s)
a molecule consisting of a hydrogen atom, a carboxyl group, and an amine group bonded to the same carbon. The group bonded to the carbon varies and is represented by an R in the structural formula
enzyme that binds to a tRNA molecule and catalyzes the addition of the correct amino acid to the tRNA
protein synthesis inhibitors that bind to the 30S subunit and interfere with the ribosome’s proofreading ability, leading to the generation of faulty proteins that insert into and disrupt the bacterial cytoplasmic membrane
intestinal infection caused by Entamoeba histolytica
severe form of intestinal infection caused by Entamoeba histolytica, characterized by severe diarrhea with blood and mucus
a molecule containing both polar and nonpolar parts
chemical reactions that convert simpler molecules into more complex ones
container devoid of oxygen used to grow obligate anaerobes
use of a non-oxygen inorganic molecule, like CO2, nitrate, nitrite, oxidized iron, or sulfate, as the final electron acceptor at the end of the electron transport system
formation of hydrogen bonds between the nucleotide base pairs of two single-stranded complementary nucleic acid sequences
Y-shaped glycoprotein molecule produced by B cells that binds to specific epitopes on an antigen
three-nucleotide sequence of a mature tRNA that interacts with an mRNA codon through complementary base pairing
When two more substances are mixed together, they liquefy due to the formation of a new compound which has a lower melting point than room temperature. This type of mixture is called a eutectic mixture and substances are called eutectic substances.
Colloidal system with a finite, usually rather small yield stress.
Use of products containing genetic material (e.g., pDNA, antisense DNA, siRNA) to treat a disease or condition, or to modify or manipulate the expression of genetic material or to alter the biological prop- erties of living cells.
Drug(s) or formulation(s) of drug(s) or dosage forms, which no longer have patent protection.
Process in which powder particles are made to aggregate to larger particles called granules.
Powder particles, which have been aggregated to form larger irregular particles, usually of 0.5–2 mm diameter.
Crystalline form of a compound in which water molecules are part of the crystal structure.
Empirical scale (of 0–20) used to classify surfactants and emulsifying agents.
Tendency of a molecule to be solvated by water.
Property of being water-repellent; tending not to absorb water.
Tendency of a substance to absorb water from the atmosphere.
Dosage form that releases the drug immediately.
Insertion or grafting of a biological, living, inert, or radioactive material into the body.
Small sterile usually polymeric matrices, pellets, or particles for insertion or implanting into the body by surgical means or by injection to help achieve sustained release.
Administration of drugs directly to the respiratory tract, mostly by aerosols.
Delivery of a generally sterile liquid medication into the body, or a vessel, tissue, or organ via syringe and needle.
Reversible formation of association colloids from surfactants in nonpolar solvents leads to aggregates termed inverted (or inverse, reverse, or reversed) micelles.
Liquid intended for massaging into the skin.
Artificial spherical lipid bilayer droplet formed mainly from phospholipids having a core of water phase, small enough to form a relatively stable dispersion in aqueous media and with potential use in drug delivery.
Initial, typically larger than the maintenance dose of a drug given to a patient at the start of pharmaco- therapy.
Solution, emulsion, or suspension to be applied to the skin.
Tablet, which does not contain a disintegrant and which is sucked to dissolve in the mouth to produce either a local (e.g., antiseptic) or systemic (e.g., vitamins) effect.
Used as processing aid in tablet and capsule manufacturing, to facilitate the movement of the formulation into the dye and punch and to reduce the energy of compression.
Denotes a dispersed phase having a pronounced affinity for the dispersion medium.
Denotes a dispersed phase having but slight affinity for the dispersion medium.
Specific case of drug embedding in insoluble excipients (typically in a polymer) in order to achieve ex- tended release.
Maximum concentration of a drug, which will form a clear solution with a given concentration of surfactant.
Concentration of a drug in the plasma, above which side effects are likely to occur in a patient.
Formation of micelles.
Emulsions in which the dispersed droplets are in the micron-size range.
Formation of microparticles encapsulating a drug.
Pressure-driven, membrane-based separation process in which particles and dissolved macromolecules larger than 0.1 micrometer are rejected.
Lowest concentration of an antibacterial drug necessary to inhibit the growth of a microorganism.
Release of a drug from a dosage form that it is not immediate (e.g., sustained release, retarded release, delayed-action preparations, controlled release, extended release, etc.).
Usually water or low-molecular-weight alcohols or compounds, used in topical applications and in wet granulation, for the production of tablets.
Dosage form (capsule, tablet) comprising several elements (e.g., microspheres or coated pellets) dif- fering in the rate of drug release.
Consists of several different layers that are compressed on top of each other, to form a single tablet com- posed of two or more layers.
Formation of nanoparticles encapsulating a drug.
Kinetic model, where the whole body is thought of as a single compartment in which a substance is dis- tributed rapidly, achieving an equilibrium between blood and tissue immediately.
Time required to achieve the minimum effective plasma concentration following administration of the dosage form.
Ointment containing >0 % of powder, dispersed in a fatty base.
Science of preparation of drugs, dosage forms, and drug delivery systems taking into account the pharmacokinetics and pharmacodynamics of the drug as well as its physical and chemical properties.
Existence of two or more different crystal structures for the same compound.
Defined for powders used pharmaceutically, according to particle sizes.
Dry solid material consisting of many, usually free flowing, fine particles. Conventionally, the title “powder” should be restricted to powder mixes for internal use and alternative terms are used for other powdered formulations presented in this way, e.g., dusting powders, which are for external use.
Exploratory activity that begins early in pharmaceutics, involving studies designed to determine the compatibility of excipients with the active substance for a biopharmaceutical; physicochemical and bioanalytical investigation in support of promising experimental formulations.
Chemically modified form of a pharmacologically active compound that has to undergo biochemical or chemical transformation before exhibiting its pharmacological effect.
Different crystalline form(s) of a solvated compound that differ in the identity and/or the stoichiometry of the solvating molecule.
Measure of the fraction of a given drug that is absorbed intact into the systemic circulation from a dosage form, relative to a recognized, clinically proven, standard dosage form of that drug.
Tablet or capsule distinguished from a sustained-release dosage form, by the fact that it releases the me- dicinal agent, or part of it, at any time other than promptly after administration as opposed to a slow, controlled manner.
Process that differentiates or separates solid particles according to their size using a meshed or perforated device.
Fluid colloidal dispersion of a solid in a liquid.
Crystalline form of a compound in which one or more solvent molecules are part of the crystal struc- ture.
Process of making dense, spherical pellets by means of special spheronizing or pelletizing equipment.
Scaffold placed into narrowed, diseased vessels (mainly coronary arteries) or a device implanted in a vessel used to help keep it open.
Condition of being aseptic, or statistically free from living microorganisms and their spores.
Sterilisation is the process of complete destruction of all microorganisms present in a system. the products free from the microorganisms called "sterile products".
Usually small, flat, and soft tablets, which are designed to be placed under the tongue to allow direct absorption of the active ingredient through the mucosa for systemic effect.
Dosage form, semi-solid, used for the administration of drugs via the rectal route, for systemic or local effect. When application is via other routes (e.g., the vaginal route), suppositories are termed differ- ently, inserts, pessaries, etc.
Substance that alters the conditions prevailing at an interface, causing, for example, a marked decrease in the surface tension of water or nonaqueous solvents.
Dosage form designed to release the drug contained therein at a continuous and controlled rate for a longer period of time that can normally be achieved with its conventional, nonsustained counterpart.
Liquid preparation of high sugar concentration with or without medicinal and additional flavouring substances.
Effect, relating to the entire organism as distinguished from any of its individual parts.
Solid dosage form compressed into a specific shape containing medicinal substances with or without suitable diluents.
Solid layers based typically on cellulose derivatives and may include plasticizers and pigments.
Ratio between toxic and therapeutic doses (the higher the ratio, the greater the safety of the therapeutic dose).
The removal of tissue from one part of the body or from one individual and its implantation or insertion in another.